TY  -  
T1  - Pregnancy outcomes after exposure to interferon beta : a register-based cohort study among women with MS in Finland and Sweden 
SN  -  /  
UR  - http://hdl.handle.net/10138/321584 
T3  -  
A1  - European Interferon Beta Pregnancy; Nordic Pregnancy Interferon Beta S; Hakkarainen, Katja Marja; Juuti, Rosa; Burkill, Sarah; Artama, Miia; Verkkoniemi-Ahola, Auli; Mehtälä, Juha; Korhonen, Pasi 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - Background Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS disease-modifying drug (MSDMD). Methods This cohort study used Finnish (1996-2014) and Swedish (2005-2014) national register data. Women with MS having IFNB dispensed 6 months before or during pregnancy as the only medication were considered as IFNB exposed (only IFNB-exposed), w... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Adverse effects; epidemiology; interferon-beta; multiple sclerosis; pregnancy; pregnancy complications; registries; MULTIPLE-SCLEROSIS; PHARMACOLOGICAL-TREATMENT; ECTRIMS/EAN GUIDELINE; EXPERIENCE; PEOPLE; SAFETY; 3112 Neurosciences; 3124 Neurology and psychiatry; 3123 Gynaecology and paediatrics 
N1  -   
PP  -  
ER  -